BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 6807523)

  • 1. Graves' ophthalmopathy and subclinical hypothyroidism: diagnostic value of the thyrotropin releasing hormone test.
    Walfish PG; Gottesman IS; Baxter JL
    Can Med Assoc J; 1982 Aug; 127(4):291-4. PubMed ID: 6807523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The many causes of subclinical hyperthyroidism.
    Charkes ND
    Thyroid; 1996 Oct; 6(5):391-6. PubMed ID: 8936661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
    Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
    Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TRH test: its value in the diagnosis of Graves' ophthalmopathy.
    Jackson WB; Tolis G; Chertman M
    Can J Ophthalmol; 1978 Jan; 13(1):10-4. PubMed ID: 416892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical Graves' disease as a cause of subnormal TSH levels in euthyroid subjects.
    Kasagi K; Takeuchi R; Misaki T; Kousaka T; Miyamoto S; Iida Y; Konishi J
    J Endocrinol Invest; 1997 Apr; 20(4):183-8. PubMed ID: 9211123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term hyperthyroidism followed by transient pituitary hypothyroidism in a very low birth weight infant born to a mother with uncontrolled Graves' disease.
    Higuchi R; Kumagai T; Kobayashi M; Minami T; Koyama H; Ishii Y
    Pediatrics; 2001 Apr; 107(4):E57. PubMed ID: 11335778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
    Khoo DH; Eng PH; Ho SC; Tai ES; Morgenthaler NG; Seah LL; Fong KS; Chee SP; Choo CT; Aw SE
    Thyroid; 2000 Dec; 10(12):1093-100. PubMed ID: 11201855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
    Bayer MF; Kriss JP; McDougall IR
    J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypothyroidism and endocrine orbitopathy].
    Wiesli P; Knierim M; Knierim C; Schmid C
    Praxis (Bern 1994); 2000 Oct; 89(40):1612-5. PubMed ID: 11081360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sub-biochemical hypothyroidism: an exaggerated thyroid stimulating hormone response to thyrotrophin releasing hormone.
    Sheth JJ; Thakore PB; Trivedi BB; Shah NN; Vaidya RA
    J Assoc Physicians India; 1999 Mar; 47(3):275-9. PubMed ID: 10999119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
    Buerklin EM; Schimmel M; Utiger RD
    J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease.
    Wiersinga WM; Smit T; van der Gaag R; Koornneef L
    J Endocrinol Invest; 1988 Sep; 11(8):615-9. PubMed ID: 2907524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of thyroid function with hormone assays.
    Liewendahl K
    Ann Chir Gynaecol; 1983; 72(3):84-9. PubMed ID: 6414358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of thyrotropin measurement by immunoradiometric assay and thyrotropin-releasing hormone test].
    Luo GC
    Zhonghua Yi Xue Za Zhi; 1993 Jun; 73(6):355-7, 382. PubMed ID: 8258107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current aspects of thyroid function diagnostics. Serum T 3 level and TRH stimulation test with radioimmunologic TSH determination].
    Pickardt CR; Horn K; Scriba PC
    Internist (Berl); 1972 Apr; 13(4):133-40. PubMed ID: 4113173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.